Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
about
Geriatric assessment for oncologistsIntegrating Geriatric Assessment into Decision-Making after Prostatectomy: Adjuvant Radiotherapy, Salvage Radiotherapy, or None?Radiation therapy for older patients with brain tumorsThe G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional studyChemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE)Geriatric screening tools are of limited value to predict decline in functional status and quality of life: results of a cohort study.G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy.One-Year Mortality in Older Patients with Cancer: Development and External Validation of an MNA-Based Prognostic ScoreRole of geriatric intervention in the treatment of older patients with cancer: rationale and design of a phase III multicenter trial.Optimizing the G8 Screening Tool for Older Patients With Cancer: Diagnostic Performance and Validation of a Six-Item Version.Adjuvant chemotherapy and HER-2-directed therapy for early-stage breast cancer in the elderly.Utility of the Edmonton Frail Scale in identifying frail elderly patients during treatment of colorectal cancer.Comprehensive geriatric assessment in 326 older women with early breast cancer.The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment.Use of geriatric assessment and screening tools of frailty in elderly patients with prostate cancer. Review.Prostate Biopsy in Active Surveillance Protocols: Immediate Re-biopsy and Timing of Subsequent Biopsies.How are elderly patients treated after a diagnosis of metastatic colorectal cancer in real-life practice? A study in a French teaching hospital.Predictive factors of depressive symptoms of elderly patients with cancer receiving first-line chemotherapy.Diagnostic performance of gait speed, G8 and G8 modified indices to screen for vulnerability in older cancer patients: the prospective PF-EC cohort study.Modeling individual and relative accuracy of screening tools in geriatric oncology.Which better predicts mortality among older men, a prostate cancer (PCa) diagnosis or vulnerability on the Vulnerable Elders Survey (VES-13)? A retrospective cohort study.Geriatric assessment is superior to oncologists' clinical judgement in identifying frailty.Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol.Prognostic role of a comprehensive geriatric assessment on the management of elderly patients with advanced non-small cell lung cancer (NSCLC): a pooled analysis of two prospective phase II trials by the GFPC Group.Impact of geriatric assessment for the therapeutic decision-making of breast cancer: results of a French survey. AFSOS and SOFOG collaborative work.Glioblastoma in elderly patients: solid conclusions built on shifting sand?What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper.Using Information Technology in the Assessment and Monitoring of Geriatric Oncology Patients.The Impact of Advancing Age on Recurrence and Survival Following Major Hepatectomy for Colorectal Liver Metastases.Comprehensive Geriatric Assessment and quality of life after localized prostate cancer radiotherapy in elderly patients.Improvement of decision-making criteria for the care of elderly cancer patients by general practitioners (Lorraine, France).Predictive values of two frailty screening tools in older patients with solid cancer: a comparison of SAOP2 and G8
P2860
Q26771403-9E1ECCA5-A136-446A-AEA6-C90976C1FBF9Q26777128-CF75E3E5-6DFD-4FDB-A623-8550F71C120EQ33815025-7108F97C-5A9E-46CC-B6F6-CB1F0C603B21Q33825402-7DEA9152-15AA-4015-99A1-158A461C7518Q33901450-26284A02-ABDF-4EEA-886C-888D226E6064Q35174349-DBB470A3-194E-4D6D-B894-7E986FF7E93EQ35836618-3DEBE149-F079-4BFB-B3D8-F8D93827F891Q35918084-D8F8CF1D-925D-4525-9D9E-76C1F6A4C27FQ36210646-1F94B986-EBC2-4EA5-A1A6-2752BB3861D0Q36558425-4946CB38-E3B9-40C0-B3D4-A31753765923Q37570641-ED1D5C84-7F09-41F0-8577-2DC45FEBDEF9Q37677549-7CE529A6-414B-423E-A012-8CEDA3AE5A39Q38630293-D233921E-B111-404B-A6AC-0C2D5146C6FBQ38672321-F1E2C2A3-368E-4DAC-B264-98CA250913F3Q39085255-9A459987-2A35-4F61-925E-4B36020B0F26Q39356200-F62B970E-18CC-49E1-8E0E-F944811C1884Q39418123-18F39BA3-B545-4A2D-9270-5186AA9E059AQ39969990-25E0D5A9-1950-43B4-A1EB-959E86440EEEQ40053330-649114E3-488D-4273-9CFC-2A03D659B3E8Q40281171-4277FD82-014B-4E8C-8E67-843154BB685FQ40394555-6A3050BE-4622-4F12-886B-47543544A0DBQ41431242-3E4C8EB4-467A-4607-BF22-673DAA489001Q41438678-4E3D367F-03CC-4117-85DA-91BC550D1E98Q47096671-E99C2059-4293-42B2-9F27-59228046422EQ47306058-06F6B9EA-77F8-4778-A1F6-6A567D3B99E2Q47827482-5551D33A-429B-400A-9496-5A2509E7EECEQ50045189-463ED7CC-79D6-4268-B089-F6596426859FQ52364992-BDEC7C83-C8AE-451A-95FC-57B3A6FF21AFQ52813512-98F96321-E084-4777-9404-6C9D9C446DD8Q55348037-488F4EA6-89A1-4B09-B40F-A3C16E06080BQ55383240-BC2E9A62-98B8-4784-AA77-586340FCDDA8Q58738677-DDA4B75C-897A-419E-AFF1-4B30029D48E4
P2860
Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Screening for vulnerability in ...... tive Multicenter Cohort Study.
@ast
Screening for vulnerability in ...... tive Multicenter Cohort Study.
@en
Screening for vulnerability in ...... tive Multicenter Cohort Study.
@nl
type
label
Screening for vulnerability in ...... tive Multicenter Cohort Study.
@ast
Screening for vulnerability in ...... tive Multicenter Cohort Study.
@en
Screening for vulnerability in ...... tive Multicenter Cohort Study.
@nl
prefLabel
Screening for vulnerability in ...... tive Multicenter Cohort Study.
@ast
Screening for vulnerability in ...... tive Multicenter Cohort Study.
@en
Screening for vulnerability in ...... tive Multicenter Cohort Study.
@nl
P2093
P2860
P1433
P1476
Screening for vulnerability in ...... tive Multicenter Cohort Study.
@en
P2093
Catherine Terret
Christophe Desauw
Cécile Mertens
Damien Heitz
Gilles Albrand
Hervé Curé
Hubert Rousselot
Isabelle van Praagh
Jean Goyard
Jean-Emmanuel Kurtz
P2860
P304
P356
10.1371/JOURNAL.PONE.0115060
P407
P577
2014-12-11T00:00:00Z